Patents by Inventor Roger Kenneth Whealands Smith

Roger Kenneth Whealands Smith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical Kits Comprising Mesenchymal Stem Cells
    Publication number: 20170258848
    Abstract: A method of treating a natural soft skeletal tissue injury in a patient the method comprising administering to the patient a composition of mesenchymal stem cells in liquid suspension enriched compared to the natural source of said cells, or tenocytes derived therefrom. The method is particularly suited to the regeneration of tendons in competitive mammals, such as the superficial digital flexor tendon of the horse.
    Type: Application
    Filed: February 24, 2017
    Publication date: September 14, 2017
    Inventors: Roger Kenneth Whealands Smith, Kenneth Gregory McGarrell, Allen Edward Goodship, Gordon William Blunn
  • Pharmaceutical Kits Comprising Mesenchymal Stem Cells
    Publication number: 20150017145
    Abstract: A method of treating a natural soft skeletal tissue injury in a patient the method comprising administering to the patient a composition of mesenchymal stem cells in liquid suspension enriched compared to the natural source of said cells, or tenocytes derived therefrom. The method is particularly suited to the regeneration of tendons in competitive mammals, such as the superficial digital flexor tendon of the horse.
    Type: Application
    Filed: September 16, 2014
    Publication date: January 15, 2015
    Applicant: RECELLERATE, INC.
    Inventors: Roger Kenneth Whealands Smith, Kenneth Gregory McGarrell, Allen Edward Goodship, Gordon William Blunn
  • PHARMACEUTICAL KITS COMPRISING MESENCHYMAL STEM CELLS
    Publication number: 20130039896
    Abstract: A method of treating a natural soft skeletal tissue injury in a patient the method comprising administering to the patient a composition of mesenchymal stem cells in liquid suspension enriched compared to the natural source of said cells, or tenocytes derived therefrom. The method is particularly suited to the regeneration of tendons in competitive mammals, such as the superficial digital flexor tendon of the horse.
    Type: Application
    Filed: July 17, 2012
    Publication date: February 14, 2013
    Inventors: Roger Kenneth Whealands Smith, Kenneth Gregory McGarrell, Allen Edward Goodship, Gordon Williams Blunn
  • PHARMACEUTICAL KITS COMPRISING MESENCHYMAL STEM CELLS
    Publication number: 20120230960
    Abstract: A method of treating a natural soft skeletal tissue injury in a patient the method comprising administering to the patient a composition of mesenchymal stem cells in liquid suspension enriched compared to the natural source of said cells, or tenocytes derived therefrom. The method is particularly suited to the regeneration of tendons in competitive mammals, such as the superficial digital flexor tendon of the horse.
    Type: Application
    Filed: May 15, 2012
    Publication date: September 13, 2012
    Inventors: Roger Kenneth Whealands Smith, Kenneth Gregory McGarrell, Allen Edward Goodship, Gordon William Blunn
  • Pharmaceutical kits comprising mesenchymal stem cells
    Patent number: 8178084
    Abstract: A method of treating a natural soft skeletal tissue injury in a patient the method comprising administering to the patient a composition of mesenchymal stem cells in liquid suspension enriched compared to the natural source of said cells, or tenocytes derived therefrom. The method is particularly suited to the regeneration of tendons in competitive mammals, such as the superficial digital flexor tendon of the horse.
    Type: Grant
    Filed: September 8, 2003
    Date of Patent: May 15, 2012
    Assignee: Quy Biosciences Limited
    Inventors: Roger Kenneth Whealands Smith, Kenneth Gregory McGarrell, Allen Edward Goodship, Gordon William Blunn